two new opioid formulations, Oxecta and Lazanda
October 2011
You'll hear about two new opioid formulations, Oxecta and Lazanda.
Oxecta (OX-ec-tah) is a new tamper-resistant, immediate-release oxycodone tab. It's formulated to discourage potential abusers from crushing, chewing, snorting, or injecting the opioid.
The tab breaks into chunks instead of a powder if crushed...and turns into a gel if mixed with liquid. It also contains sodium laurel sulfate, which irritates the nose if it's snorted.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote